Your browser doesn't support javascript.
loading
Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review.
Halderman, Ashleigh A; Ryan, Matthew W; Marple, Bradley F; Sindwani, Raj; Reh, Douglas D; Poetker, David M.
  • Halderman AA; 1 Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern, Dallas, Texas.
  • Ryan MW; 1 Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern, Dallas, Texas.
  • Marple BF; 1 Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern, Dallas, Texas.
  • Sindwani R; 2 Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Reh DD; 3 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland.
  • Poetker DM; 4 Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin.
Am J Rhinol Allergy ; 32(4): 258-268, 2018 Jul.
Article en En | MEDLINE | ID: mdl-29745243
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Telangiectasia Hemorrágica Hereditaria / Epistaxis / Inhibidores de la Angiogénesis / Bevacizumab / Inmunoterapia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Telangiectasia Hemorrágica Hereditaria / Epistaxis / Inhibidores de la Angiogénesis / Bevacizumab / Inmunoterapia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article